1.Cell Rep: Uncovering the new molecular mechanism of tumor suppressor p53-induced cancer cell death doi: 10.1016 / j.celrep.2020.03.011 There has been an ongoing battle between cancer cells and p53. P53 is […]
Aprea Therapeutics is a Boston-based biopharmaceutical company focused on developing and commercializing innovative cancer therapies that reactivate the tumor suppressor protein p53. Recently, the company announced that the U.S. food […]
In a new study, using advances in nanotechnology, researchers have found that restoring p53 not only delays the growth of p53-deficient liver and lung cancer cells, but may also make cancer drugs mTOR inhibitors […]
A recent study published in the journal Cell Reports reveals that the famous tumor suppressor gene p53 and the development of neural tubes in female embryos are surprisingly critical. The […]
P53 is a well-known human anticancer protein, known as the guardian of the human genome. Wild-type p53 (WTp53) are widely found in nature. Recently, scientists from the University of California found […]
Introduction P53 tumor suppressor gene is a kind of gene that inhibits cells from transforming into cancer cells in living organisms. There are oncogene and tumor suppressor gene in the […]